Octreotide FDA Link Generic

A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.

Also Known As:

Sandostatin; Octreotide Acetate; Compound 201-995; Octreotide Acetate Salt; SAN 201-995; SM 201-995; SMS 201-995; Sandostatine; Sandoz 201-995; Compound 201 995; Compound 201995; SAN 201 995; SAN 201995; SM 201 995; SM 201995; SMS 201 995; SMS 201995; Sandoz 201 995; Sandoz 201995; L-Cysteinamide, D- phenylalanyl- L- cysteinyl- L- phenylalanyl- D- tryptophyl- L- lysyl- L- threonyl- N- (2- hydroxy- 1- (hydroxymethyl)propyl)- , cyclic (2-7)-disulfide, (R-(R*,R*))-

Pharmalogical Action Categories:

Antineoplastic Agents, Hormonal
Gastrointestinal Agents

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Octreotide: 5228
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Octreotide: 5228

DTPA- benzyl- acetamido- D- Phe(1),Tyr(3)- octreotide

Bio-Agent Context: Research Results